In summary, our findings reveal that GBM cell MAP4K1 not only plays an oncogenic role in cell proliferation and tumor growth but also autonomously remodels the tumor immune microenvironment by resisting the trafficking of CD8+ TILs to tumor sites. The gene discussed is MAP4K1; the disease is neoplasm.